[Form 4] Delek US Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Director Ezra Uzi Yemin reported open-market sales totaling 55,356 shares of Delek US Holdings, Inc. common stock on March 18, 2026. The trades were executed at weighted average prices of $43.73 and $44.20 per share, across price ranges from $43.07 to $44.48.

After these sales, Yemin holds 228,419 shares directly and 569,651 shares indirectly through Yemin Investments, LP. The transactions were made under a pre-arranged Rule 10b5-1 trading plan, which indicates the timing was scheduled in advance rather than opportunistic.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yemin Ezra Uzi

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S(1)		3,537	D	$44.2(2)	236,744	D
Common Stock	03/18/2026		S(1)		8,325	D	$43.73(3)	228,419	D
Common Stock	03/18/2026		S(1)		12,969	D	$44.2(2)	600,176	I	By Yemin Investments, LP
Common Stock	03/18/2026		S(1)		30,525	D	$43.73(3)	569,651	I	By Yemin Investments, LP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

2. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $43.07 per share to a high sale price of $44.06 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

3. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $44.07 per share to a high sale price of $44.48 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.

Remarks:

	/s/ Ezra Uzi Yemin	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Ezra Uzi Yemin report for Delek US (DK)?

Ezra Uzi Yemin reported open-market sales totaling 55,356 shares of Delek US common stock on March 18, 2026. The filing shows multiple trades at weighted average prices near $44 per share executed on the same day.

At what prices did Ezra Uzi Yemin sell Delek US (DK) shares?

The reported sales were executed at weighted average prices of $43.73 and $44.20 per share. Footnotes state these averages reflect multiple trades between $43.07 and $44.48 per share during the trading day.

How many Delek US (DK) shares does Ezra Uzi Yemin hold after the reported sales?

After the transactions, Yemin holds 228,419 shares of Delek US common stock directly. He also has 569,651 shares held indirectly through Yemin Investments, LP, according to the ownership details in the filing.

Were Ezra Uzi Yemin’s Delek US (DK) share sales under a 10b5-1 plan?

Yes. A footnote explains the transactions were made pursuant to a Rule 10b5-1 trading plan. Such plans pre-schedule trades, providing an affirmative defense that the timing was not based on nonpublic information.

Does the Delek US (DK) Form 4 show any option exercises or derivative trades?

No derivative transactions are listed in this Form 4. The filing’s summary shows only non-derivative open-market sales of common stock, with derivative transaction counts and shares both reported as zero.

How many total Delek US (DK) shares did Ezra Uzi Yemin sell in this Form 4?

The Form 4 aggregates 55,356 shares sold in four open-market transactions. All trades involved Delek US common stock and are coded as “S” sales, indicating dispositions rather than purchases or grants.